Showing 1 - 1 results of 1 for search 'Vivek Pradhan', query time: 0.01s Refine Results
  1. 1
    Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study

    Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study by Ravi Shankar P. Singh, Vivek Pradhan, Erika S. Roberts, Matthew Scaramozza, Elizabeth Kieras, Jeremy D. Gale, Elena Peeva, Michael S. Vincent, Anindita Banerjee, Andrew Fensome, Martin E. Dowty, Peter Winkle, Christopher Tehlirian

    Published 2021
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: